Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Overexpression of the flagellar motor protein MotB sensitizes Bacillus subtilis to aminoglycosides in a motility-independent manner

  • Mio Uneme,

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

    Affiliation Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  • Kazuya Ishikawa,

    Roles Data curation, Formal analysis, Funding acquisition, Writing – review & editing

    Affiliation Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  • Kazuyuki Furuta,

    Roles Data curation, Formal analysis, Funding acquisition, Writing – review & editing

    Affiliation Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  • Atsuko Yamashita,

    Roles Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

    Affiliation Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

  • Chikara Kaito

    Roles Conceptualization, Funding acquisition, Supervision, Writing – review & editing

    ckaito@okayama-u.ac.jp

    Affiliation Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan

Abstract

The flagellar motor proteins, MotA and MotB, form a complex that rotates the flagella by utilizing the proton motive force (PMF) at the bacterial cell membrane. Although PMF affects the susceptibility to aminoglycosides, the effect of flagellar motor proteins on the susceptibility to aminoglycosides has not been investigated. Here, we found that MotB overexpression increased susceptibility to aminoglycosides, such as kanamycin and gentamicin, in Bacillus subtilis without affecting swimming motility. MotB overexpression did not affect susceptibility to ribosome-targeting antibiotics other than aminoglycosides, cell wall-targeting antibiotics, DNA synthesis-inhibiting antibiotics, or antibiotics inhibiting RNA synthesis. Meanwhile, MotB overexpression increased the susceptibility to aminoglycosides even in the motA-deletion mutant, which lacks swimming motility. Overexpression of the MotB mutant protein carrying an amino acid substitution at the proton-binding site (D24A) resulted in the loss of the enhanced aminoglycoside-sensitive phenotype. These results suggested that MotB overexpression sensitizes B. subtilis to aminoglycosides in a motility-independent manner. Notably, the aminoglycoside-sensitive phenotype induced by MotB requires the proton-binding site but not the MotA/MotB complex formation.

Introduction

The efficacy of antimicrobials is affected by various cellular activities, including drug uptake and efflux, degradation, changes in drug targets, and respiratory pathways. Identifying bacterial factors that affect antibiotic efficacy is important for developing novel drugs that suppress antibiotic-resistant bacteria.

Aminoglycosides are bactericidal antibiotics used against Gram-negative and Gram-positive bacteria. Aminoglycosides target the 30S subunit of the ribosome and exert their bactericidal activity by inhibiting protein synthesis [1,2]. The bactericidal activity of aminoglycosides requires the proton motive force (PMF) of the bacterial cell membrane [35]. The reason why PMF is required for the action of aminoglycosides is largely unclear, although it is widely accepted that the uptake of positively charged aminoglycosides requires an electric potential difference between the inside and outside of the bacterial cell membrane [4]. Several studies have proposed that the reactive oxygen species produced by aerobic respiration [6] or dysregulation of the electric potential of the bacterial cell membrane [7] affect the bactericidal action of aminoglycosides. In both cases, the PMF of the bacterial cell membrane played an important role in the efficacy of aminoglycosides. Previous studies have revealed that mutations in the electron transport complex [8,9] or F1Fo-ATP synthase [7,10,11], which directly change PMF, alter susceptibility to aminoglycosides or its uptake. However, other bacterial factors that affect the electric potential difference in the bacterial cell membrane and susceptibility to aminoglycosides have not been identified.

Many bacterial species use their flagella to move in liquid or host environments [12]. The bacterial flagellum is a multi-protein complex comprising more than 25 proteins, but its basic structure and rotating mechanism are well conserved across bacterial genera. The bacterial flagellum has three components: basal body, hook, and filament [13]. The basal body is embedded in the bacterial cell membrane and functions as a motor. The hook connects the basal body to the filament and transmits the torque generated by the motor to the filament protruding outside the cell [14]. The driving force of the flagellar motor is the flow of ions through the stator complexes of the flagellar motor. The flagellar stator is a hetero-heptameric membrane protein complex consisting of five A subunits and two B subunits [15,16]. Escherichia coli and Salmonella spp. have a proton-driven stator, MotA/MotB, whereas Vibrio spp. in the oceanic environment have a sodium ion-driven stator, PomA/PomB [1720]. Bacillus subtilis uses both stator complexes, proton-driven MotA/MotB and sodium ion-driven MotP/MotS [YtxD/YtxE], in response to the external environment [2123].

We hypothesized that proton transfer by MotA/MotB affects bacterial susceptibility to aminoglycosides. Here, we demonstrated that the overexpression of MotB sensitizes B. subtilis to aminoglycosides. Unexpectedly, the aminoglycoside-sensitive phenotype induced by MotB did not require the formation of a complex with MotA. Furthermore, MotB overexpression increased the sensitivity to aminoglycosides without affecting B. subtilis motility. We propose that overexpressed MotB increases the susceptibility to aminoglycosides in a motility-independent manner. Moreover, we provide an implication for the link between motor proteins and antibiotic susceptibility.

Results

Overexpression of MotB makes B. subtilis sensitive to aminoglycosides without affecting the motility

We examined the effects of MotA and MotB on the susceptibility of B. subtilis to aminoglycosides. The motA- and motB-deletion mutants showed survival similar to that of the wildtype strain in the presence of kanamycin or gentamicin (Fig 1A). In contrast, the MotB-overexpressed strain displayed decreased survival in the presence of kanamycin or gentamicin compared to the vector-transformed strain but showed similar survival or growth to the vector-transformed strain in the absence of these antibiotics (Fig 1B and S1 Fig). The survival of the MotA-overexpressed strain was similar to that of the vector-transformed strain in the presence of kanamycin or gentamicin (Fig 1B). In the presence of kanamycin, the strain that overexpressed both MotA and MotB showed decreased survival compared to the vector-transformed strain but showed survival similar to that of the MotB-overexpressed strain (Fig 1B). These results suggested that MotB overexpression sensitizes B. subtilis to aminoglycosides, but MotA overexpression does not.

thumbnail
Fig 1. Overexpression of MotB leads to an aminoglycoside-sensitive phenotype in B. subtilis without altering its motility.

A. Overnight cultures of the vector-transformed strain (WT/EV), motB-deletion strain (ΔmotB/EV), and motA-deletion strain (ΔmotA/EV) strain, serially diluted (10-fold) and spotted on LB agar containing 1 mM IPTG with or without kanamycin (1.5 μg/mL) or gentamicin (0.75 μg/mL), and incubated at 37°C. EV means that the strain was transformed using pDR110, an empty vector. Data shown are the means ± standard errors from a minimum of three independent experiments. Statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test. B. Overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motBOE), MotA-overexpressed strain (WT/motAOE), and MotA/MotB-overexpressed strain (WT/motABOE), serially diluted (10-fold) and spotted on LB agar containing 1 mM IPTG with or without kanamycin (1.2 μg/mL) or gentamicin (0.5 μg/mL), and incubated at 37°C. Data shown are the means ± standard errors from a minimum of three independent experiments. Statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test. *, p < 0.05; **, p < 0.01. C. The swimming motility of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motBOE), motB-deletion strain (ΔmotB/EV), and motB-deletion strain overexpressing MotB (ΔmotB/motBOE) on 0.3% soft agar medium containing 1 mM IPTG. Data shown are the means ± standard errors from five independent experiments. Statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test. ****, p < 0.0001. D. Histograms and normal distribution curves of the single-cell speeds of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motBOE), motB-deletion strain (ΔmotB/EV), and motB-deletion strain overexpressing MotB (ΔmotB/motBOE) in LB medium with 1 mM IPTG. ΔmotB/EV was significantly different from WT/EV and ΔmotB/motBOE (p < 0.05), but WT/motBOE was not significantly different from WT/EV (p = 0.73). Statistical analyses were performed using Kolmogorov-Smirnov tests.

https://doi.org/10.1371/journal.pone.0300634.g001

Next, we examined if MotB overexpression affects B. subtilis motility. To evaluate the motility of each strain, we observed spreading in semi-solid agar plates. Notably, there was no significant difference in the motility between the vector-transformed strain and the MotB-overexpressed strain (Fig 1C). In these assay conditions, the motB-deletion mutant showed decreased motility compared to the wildtype strain, and motility was restored by MotB overexpression (Fig 1C). To compare the motility of each strain more directly, we measured the swimming speed of single cells using a microscope. There was no significant difference in the swimming speed between the vector-transformed strain and the MotB-overexpressed strain (Fig 1D). The swimming speed of the motB-deletion mutant was decreased compared to the wildtype strain, and the speed was increased by MotB overexpression to a similar extent as the MotB-overexpressed wildtype strain (Fig 1D). Overexpression of MotB in the wildtype strain did not affect the swimming speed but made a difference in the susceptibility to aminoglycosides, suggesting no correspondence between the bacterial swimming speed and the aminoglycoside-sensitive phenotype. Taken together, these results indicate that MotB overexpression leads to an aminoglycoside-sensitive phenotype without affecting motility.

Overexpression of MotB sensitizes B. subtilis to aminoglycosides in the absence of MotA

MotB forms a complex with MotA and functions as a flagellar motor [24]. We examined the requirement of MotA for the aminoglycoside-sensitive phenotype caused by MotB overexpression. Overexpression of MotB in the motA-deletion mutant resulted in decreased survival compared to that in the vector-transformed motA-deletion mutant in the presence of kanamycin or gentamicin (Fig 2). This result suggests that MotA is not required for the aminoglycoside-sensitive phenotype caused by MotB overexpression.

thumbnail
Fig 2. Overexpression of MotB causes the aminoglycoside-sensitive phenotype independent of MotA.

Overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motB-FLAGOE), motA-deletion strain (ΔmotA/EV), and MotB-overexpressing motA-deletion strain (ΔmotA/motB-FLAGOE), serially diluted (10-fold) and spotted on LB agar containing 1 mM IPTG with or without kanamycin (1.5 μg/mL) or gentamicin (0.5 μg/mL), and incubated at 37°C. Data shown are the means ± standard errors from a minimum of three independent experiments. Statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test. **, p < 0.01; ***, p < 0.001.

https://doi.org/10.1371/journal.pone.0300634.g002

Overexpression of MotB sensitizes B. subtilis only to aminoglycosides

We examined whether MotB overexpression affects B. subtilis susceptibility to antimicrobials other than aminoglycosides. The survival of the MotB-overexpressed strain was similar to that of the vector-transformed strain in the presence of ribosome-targeting antibiotics other than aminoglycosides, including erythromycin, chloramphenicol, and tetracycline (Fig 3). In addition, the MotB-overexpressed strain showed survival similar to that of the vector-transformed strain in the presence of cell wall-targeting antibiotics, including vancomycin and ampicillin, DNA synthesis-inhibiting antibiotics, including ciprofloxacin and levofloxacin, and an RNA synthesis-inhibiting antibiotic, rifampicin (Fig 3). The minimum inhibitory concentrations (MICs) for kanamycin and gentamicin of the MotB-overexpressed strain decreased approximately 1.5-fold compared with those of the vector-transformed strain, but the MICs for the other drugs were the same between the MotB-overexpressed strain and the vector-transformed strain (Table 1). These results suggest that MotB overexpression does not affect susceptibility to antimicrobials other than aminoglycosides and leads to sensitive phenotypes specific to aminoglycosides.

thumbnail
Fig 3. Overexpression of MotB does not alter B. subtilis susceptibility to antibiotics other than aminoglycosides.

Overnight cultures of the vector-transformed strain (WT/EV) and the MotB-overexpressed strain (WT/motBOE), serially diluted (10-fold) and spotted on LB agar medium containing 1 mM IPTG with or without ampicillin (0.2 μg/mL), vancomycin (0.2 μg/mL), erythromycin (0.1 μg/mL), chloramphenicol (1 μg/mL), tetracycline (3.5 μg/mL), levofloxacin (50 ng/mL), ciprofloxacin (50 ng/mL), or rifampicin (30 ng/mL), and incubated at 37°C. Data shown are the means ± standard errors from a minimum of three independent experiments. Statistical analyses were calculated using a one-way ANOVA with Dunnett’s multiple comparisons test.

https://doi.org/10.1371/journal.pone.0300634.g003

thumbnail
Table 1. MIC values of the MotB-overexpressed strain against various antibiotics.

https://doi.org/10.1371/journal.pone.0300634.t001

Overexpression of MotS, a homolog of MotB, does not sensitize B. subtilis to aminoglycosides

In B. subtilis, MotP/MotS converts the transmembrane gradient of sodium ions into energy for flagellar rotation in response to environmental changes, such as salinity changes [2123]. Since MotS is homologous to MotB [21], we examined whether MotS overexpression sensitizes B. subtilis to aminoglycosides. The survival of the MotS-overexpressed strain was similar to that of the vector-transformed strain in the presence of kanamycin or gentamicin (Fig 4A). In addition, the strain overexpressing MotS and MotP, the homolog of MotA, showed survival similar to that of the vector-transformed strain in the presence of kanamycin or gentamicin (Fig 4A).

thumbnail
Fig 4. Overexpression of MotS, a homolog of MotB, does not cause the aminoglycoside-sensitive phenotype.

A. Overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motBOE), MotS-overexpressed strain (WT/motSOE), and MotP/MotS-overexpressed strain (WT/motPSOE), serially diluted (10-fold) and spotted on LB agar containing 1 mM IPTG with or without kanamycin (1.5 μg/mL) or gentamicin (0.5 μg/mL), and incubated at 37°C. Data shown are the means ± standard errors from three independent experiments. Statistical analyses were calculated using a one-way ANOVA with Dunnett’s multiple comparisons test. **, p < 0.01. B. Western blot using an anti-FLAG antibody for the whole cell fraction extracted from overnight cultures of the vector-transformed strain (EV), MotB-overexpressed strain (motB-FLAGOE), and MotS-overexpressed strain (motS-FLAGOE).

https://doi.org/10.1371/journal.pone.0300634.g004

To confirm the expression of MotS and MotB, a FLAG tag sequence was fused to the C-terminus of motS or motB. Western blot analyses confirmed MotS-FLAG and MotB-FLAG expressions (Fig 4B, S1 Raw images). These results suggest that the specific function of MotB, which does not exist in MotS, leads to susceptibility to aminoglycosides.

The proton-binding site of MotB is important for the aminoglycoside-sensitive phenotype

When MotA/MotB or MotP/MotS function as a complex, MotB or MotS have been shown to be the major determinants of ion bindings [25]. Based on the finding that overexpression of MotS, which binds sodium ions, did not cause an aminoglycoside-sensitive phenotype, we examined whether the proton-binding site of MotB plays a role in the aminoglycoside-sensitive phenotype. Based on reports that Asp24 of MotB electrically interacts with protons to achieve proton transport in B. subtilis [26,27], we generated motB mutant genes with Asp24 substituted with Ala (D24A) or Glu (D24E). Based on the amino acid characteristics, D24A MotB does not interact with protons, whereas D24E MotB mimics the interaction of wildtype MotB with protons [27]. All motB genes were fused to a FLAG tag sequence at the C-terminus to examine the localization of the overexpressed MotB. The D24A MotB-overexpressed strain did not show significantly decreased survival compared with the vector-transformed strain in the presence of kanamycin or gentamicin (Fig 5A). In contrast, in the presence of kanamycin, the D24E MotB-overexpressed strain showed less survival than the vector-transformed strain (Fig 5A). Next, to examine the possibility that the amino acid substitutions in MotB affect subcellular localization, cytosolic and membrane fractions were prepared from these strains, and wildtype and mutant MotB proteins were detected by western blotting. FoF1-ATP synthase subunit a (AtpB; [28]) and an RNA polymerase sigma factor (SigB; [29,30]) were used as marker proteins for the membrane fraction and the cytosolic fraction, respectively. Wildtype MotB, D24A MotB, and D24E MotB were not detected in the cytosolic fraction in which the cytosolic protein SigB was detected (Fig 5B, S2 Raw images). These proteins were only detected in the membrane fraction in which the membrane protein AtpB was detected (Fig 5B, S2 Raw images). The expression of D24A MotB was higher than that of wildtype MotB, whereas that of D24E MotB was comparable to that of wildtype MotB (Fig 5B, S2 Raw images). These results suggest that D24A MotB loses its activity, whereas D24E MotB retains it, leading to an aminoglycoside-sensitive phenotype. These findings suggest that the proton-binding site of MotB plays an important role in the aminoglycoside-sensitive phenotype.

thumbnail
Fig 5. The proton-binding site of MotB is required for aminoglycoside sensitization.

A. Overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motB-FLAGOE), D24A MotB-overexpressed strain (WT/motB(D24A)-FLAGOE), and D24E MotB-overexpressed strain (WT/motB(D24E)-FLAGOE), serially diluted (10-fold) and spotted on LB agar containing 1 mM IPTG with or without kanamycin (1.2 μg/mL) or gentamicin (0.5 μg/mL), and incubated at 37°C. Data shown are the means ± standard errors from a minimum of four independent experiments. Statistical analyses were performed using a one-way ANOVA with Dunnett’s multiple comparisons test. *, p < 0.05; **, p < 0.01. B. Western blot using an anti-FLAG antibody for the whole cell fraction, membrane fraction, and cytosolic fraction extracted from overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motB-FLAGOE), D24A MotB-overexpressed strain (WT/motB(D24A)-FLAGOE), D24E MotB-overexpressed strain (WT/motB(D24E)-FLAGOE), AtpB-overexpressed strain (WT/atpB-FLAGOE), and SigB-overexpressed strain (WT/sigB-FLAGOE).

https://doi.org/10.1371/journal.pone.0300634.g005

The increased expression of the alanine-substituted MotB at the conserved Asp residue has also been reported in E. coli [26]. We speculate that D24A MotB was more abundant than wildtype MotB due to the structural stabilization of the MotA/MotB complex because the alanine substitution causes structural alteration of E. coli MotA/MotB [31].

Determination of MotB expression level causing aminoglycoside sensitivity

To determine the protein expression level of MotB that causes the motility activity and the aminoglycoside-sensitive phenotype, we examined the phenotypes of the motB-deletion mutant transformed with motB-FLAG, which was cultured in the presence of various concentrations of isopropyl β-D-thiogalactopyranoside (IPTG). Addition of 0.05 mM IPTG restored the motility of the motB-deletion mutant to the level of the wildtype strain (Fig 6A), but it did not cause the aminoglycoside sensitive-phenotype (Fig 6B). Addition of 0.1 mM IPTG restored the motility activity and caused the aminoglycoside-sensitive phenotype (Fig 6A and 6B). Thus, a higher concentration of IPTG (0.1 mM) is required to cause the aminoglycoside-sensitive phenotype than to cause the motility phenotype (Fig 6C). Western blot analysis revealed that the protein expression level of MotB was greater in 0.1 mM IPTG than in 0.05 mM IPTG (Fig 6D, S3 Raw images). These results suggest that larger expression levels of MotB are required to cause the aminoglycoside-sensitive phenotype than to cause the motility activity.

thumbnail
Fig 6. The overexpressed MotB exists as large protein complexes.

A. Swimming motility of the vector-transformed strain (WT/EV) and motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE) on 0.3% soft agar medium containing various concentrations of IPTG. B. Overnight cultures of the vector-transformed strain (WT/EV), MotB-overexpressed strain (WT/motB-FLAGOE), motB-deletion strain (ΔmotB/EV), and motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE), serially diluted (10-fold) and spotted on LB agar containing various concentrations of IPTG with kanamycin (1.5 μg/mL), and incubated at 37°C. C. Relationship between IPTG concentration, swimming motility, and kanamycin sensitivity in the motB-deletion strain overexpressing MotB. The CFU ratio of the motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE) to the vector-transformed strain (EV) in the presence of kanamycin is shown in the left vertical axis (orange symbols), and the swimming ratio of the motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE) to the vector-transformed strain (EV) is shown in the right vertical axis (blue symbols). Data shown are the average and range of two independent experiments including the results shown in A and B. D. Western blot for the whole cell fraction extracted from the motB-deletion strain (ΔmotB/EV) and the motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE) that were cultured in the presence of various concentrations of IPTG. E. The membrane fractions extracted from the motB-deletion strain (ΔmotB/EV) and motB-deletion strain overexpressing MotB (ΔmotB/motB-FLAGOE) that were cultured in the presence of various concentrations of IPTG were solubilized with 0.5% n-dodesyl-β-D-maltoside and subjected to blue native polyacrylamide gel electrophoresis and western blot. A black arrowhead indicates a 60 kDa band, and white arrowheads indicate 146, 180, 220, 180, and 380 kDa bands.

https://doi.org/10.1371/journal.pone.0300634.g006

To understand the MotB complexes that cause the aminoglycoside-sensitive phenotype, we performed a blue native polyacrylamide gel electrophoresis and the subsequent western blot analysis. With 0.1 mM IPTG, we detected protein bands with various sizes of 60 kDa (black arrowhead) and larger than 60 kDa (Fig 6E, S3 Raw images). The signal intensities of the 60 kDa band were comparable between 0.1 mM and 0.05 mM IPTG conditions (Fig 6E, S3 Raw images). The signal intensities of bands larger than 60 kDa were greater with 0.1 mM IPTG than with 0.05 mM IPTG (Fig 6E, S3 Raw images). We estimate that the 60 kDa band represents homodimers of MotB-FLAG because MotB has been reported to form a dimer [32], and the theoretical molecular size of the dimer of MotB-FLAG is 61 kDa. The bands with larger molecular weights may contain the MotA/MotB complex, the complex with flagellar motor, or other unknown complexes. These results suggest that overexpressed MotB exists as protein complexes to cause the aminoglycoside-sensitive phenotype.

Discussion

In this study, we found that the overexpression of MotB, a flagellar motor protein, sensitizes B. subtilis to aminoglycosides. Notably, we show that MotB leads to aminoglycoside susceptibility in a motility-independent manner. Overexpression of MotB in the motA-deletion mutant led to an aminoglycoside-sensitive phenotype, indicating that MotB induces aminoglycoside susceptibility independent of MotA. This is the first study to suggest that MotB has potential other than as a flagellar motor protein.

Overexpression of MotB did not affect B. subtilis susceptibilities to ribosome-targeting antibiotics (erythromycin, chloramphenicol, and tetracycline), DNA synthesis-inhibiting antibiotics (levofloxacin and ciprofloxacin), RNA synthesis-inhibiting antibiotics (rifampicin), or cell wall-targeting antibiotics (ampicillin and vancomycin; Fig 3). The aminoglycosides, which are affected by MotB overexpression exclusively regarding efficacy, have a structure containing an aminocyclitol ring (streptidine or 2-deoxystreptamine) and two or more amino sugars linked by glycosidic bonds to it [33]. They contain abundant basic ionizable amino groups as the substituents, which make them positively charged and strongly polar compounds [34,35] (S2 Fig). Therefore, it has been suggested that the importance of PMF is inducing their crossing of the cell membrane and uptake into the bacterial cell. Vancomycin and ampicillin target cell wall synthesis, and their uptake into bacterial cells is not required for antibiotic action [36,37]. In addition, erythromycin, chloramphenicol, tetracycline, levofloxacin, ciprofloxacin, and rifampicin are hydrophobic molecules, and their uptake into bacterial cells is unlikely to be as affected by membrane potential as aminoglycosides. Since MotB overexpression leads to susceptibility specific to aminoglycosides among the antibiotics examined in this study, MotB overexpression may change cellular activities, such as PMF, which specifically affects aminoglycoside susceptibility.

This study revealed that an amino acid substitution in the proton-binding site of MotB (D24A) affects its ability to cause an aminoglycoside-sensitive phenotype. In addition, MotB overexpression resulted in an aminoglycoside-sensitive phenotype in the motA-deletion mutant. These findings suggest that interactions MotB with MotA are not required for the phenotype but that its proton-binding site plays an important role in inducing the aminoglycoside-sensitive phenotype. We considered the possibility that MotB overexpression may change PMF by interacting with protons; however, it is difficult to imagine that MotB can bind protons and alter PMF without forming a complex with MotA. In fact, a single-cell motility assay revealed that MotB overexpression did not affect the swimming speed. Previous studies have analyzed various MotB mutants [38,39], but no studies have analyzed the function of MotB in the absence of MotA. This study revealed that overexpressed MotB exists as protein complexes. Future studies are needed to examine the effect of MotB overexpression on PMF or complex formation and the molecular mechanisms by which MotB overexpression causes the aminoglycoside-sensitive phenotype. Furthermore, in addition to the proton binding site in the transmembrane domain, MotB has the peptide glycan binding motif and the plug region, which have important roles in the regulation of proton translocation [39,40]. The requirement of these regions of MotB for inducing the aminoglycoside-sensitive phenotype should be investigated in the future.

MotB is well-conserved among various flagellated bacteria. These findings suggest that drugs that increase MotB expression have the potential to increase aminoglycoside efficacy. The molecular mechanisms that regulate motAB expression have been studied in several bacterial species. In Dickeya dadantii, SlyA regulates MotA and MotB expression via the PhoP-PhoQ two-component system [41]. In Listeria monocytogenes, motAB expression is regulated by the virulence regulator PrfA [42]. In Rhizobium leguminosarum, VisN/R-Rem regulates the expression of motAB [43]. This information regarding the regulation of motAB is important to establish research strategies for identifying drugs that activate motAB transcription. Notably, aminoglycosides have been in use since the 1940s. Drugs that increase the efficacy of aminoglycosides could be useful in combating aminoglycoside-resistant bacteria.

Materials and methods

Bacteria and culture conditions

B. subtilis 168 trpC2 and the mutant strains were aerobically cultured in LB at 37°C. B. subtilis gene deletion mutants carrying erythromycin-resistant gene or B. subtilis strain transformed with pDR110 were cultured on an LB agar plate supplemented with erythromycin (1 μg/mL) or spectinomycin (100 μg/mL), respectively. To overexpress MotB, bacterial strains were cultured in the LB medium supplemented with 1 mM IPTG. The bacterial strains and plasmids used in this study are listed in Table 2.

Gene deletion mutant

Genomic DNA was extracted from the motB-deletion mutant (BSU13680) or the motA-deletion mutant (BSU13690) [44] by using the QIAamp DNA Blood Mini Kit (Qiagen). It was used to transform B. subtilis 168 trpC2 strain [45]. Erythromycin-resistant colonies were obtained on LB plates supplemented with erythromycin (1μg/mL). The erythromycin-resistant cassette in the mutant strains was excised using pDR244, a temperature-sensitive plasmid expressing a Cre recombinase. The desired deletion of motB or motA was confirmed using PCR.

Plasmid construction

DNA fragments containing motB, motA, motAB, motS, motP, atpB, and sigB were amplified by PCR using specific primer pairs (Table 3) and a genomic DNA from 168 trpC2 as a template. The amplified DNA fragments were inserted into the multiple cloning site of pDR110, resulting in the plasmids pDR110-motB, pDR110-motA, pDR110-motAB, pDR110-motP, pDR110-motS, pDR110-motPS, pDR110-atpB-FLAG, and pDR110-sigB-FLAG.

The FLAG tag sequence was added to pDR110-motB or pDR110-motS by inverse PCR using specific primer pairs (Table 3) and pDR110-motB or pDR110-motS as a template. The desired addition of a FLAG tag at the C-terminus of MotB or MotS was confirmed by Sanger sequencing. To introduce amino acid substitutions (D24A and D24E) into MotB, thermal cycling reactions were performed using primer pairs (Table 3), pDR110-motB-FLAG as a template, and KOD Plus DNA polymerase (Toyobo). The product of the thermal cycling reaction was digested with DpnI and used to transform E. coli JM109. The plasmid was extracted, and the desired mutations were confirmed by Sanger sequencing.

Transformation

Natural transformation was performed to transform 168 trpC2 with the plasmids [45]. The colonies were selected on LB plates supplemented with spectinomycin (100 μg/mL). The desired recombination of the plasmid into the amyE locus was confirmed by PCR using primer pairs (Table 3) and genomic DNA as the template.

Evaluation of antibiotic susceptibility

The autoclaved LB agar medium was mixed with 1 mM IPTG and antimicrobials and poured into round or square dishes. B. subtilis overnight cultures were serially diluted 10-fold with LB broth in a 96-well microplate, and 5 μL of the diluted bacterial solutions were spotted onto LB plates with or without antibiotics using an 8-channel Pipetman. The plates were incubated overnight at 37°C. Colonies were photographed using a digital camera and counted.

The criteria for CFU counting were set as follows. i) When 5 or more colonies were observed in the most diluted spot, we counted the number of colonies. ii) When 4 or fewer colonies were observed in the most diluted spot, we counted the number of colonies in the next most diluted spot. iii) When the number of colonies could not be counted due to crowded colonies, we considered the number of colonies to be 20. iv) When the colonies were observed only at the edge of the spot, like a circle, we considered the number of colonies to be 10.

Evaluation of MIC

Overnight cultures in the presence of 1 mM IPTG were diluted to 104 CFU/5 μL and spotted on LB agar plates with 1 mM IPTG and serial 1.5-fold dilutions of antibiotics. The MIC was determined as the minimum concentration at which no colonies were observed. The values reported are the mean of three replicates.

Swimming motility assay

2 μL of an OD600-adjusted overnight culture was inoculated at the center of LB plates [0.3% (W/V) agar] containing 1 mM IPTG. After incubation at 37°C for 24 h, the diameter of the bacterial spread was measured.

Single-cell motility assay

For observation of single-cell motility, a previously described method [46] was used with modifications. Plastic tape pieces, 20 mm long, were used as spacers between coverslips. A 7-mm square in the middle of the tape was cut out to create a chamber, and 3 μL of overnight culture mixed with 7 μL of fresh LB (1 mM IPTG) was placed in the chamber. This experiment was visualized using a confocal laser scanning microscope (FV3000RS, Olympus) with a 100× objective (UPLAPO100XOHR, Olympus). Images were recorded at 5 frames per second for 20 seconds. For image analysis, cell edges in all images were highlighted by replacing each pixel with the neighborhood variance using the Variance tool in ImageJ [47] (https://imagej.net/ij/). Single-cell motility was analyzed using the TrackMate tool [48] (https://imagej.net/plugins/trackmate/) and the Simple LAC tracker was used for tracking. Track times (between the first spot of the track in time and the last spot of the track in time) of each cell were measured, and cells with a track time longer than 5.16 seconds were extracted to measure the following parameters: mean straight line speed (defined as the net displacement [Track displacement feature] divided by the track total time). To unify the number of cells used for statistical analyses, 80 cells of each strain were randomly selected. Histograms and normal distribution curves were created, and statistical significances were determined by Kolmogorov-Smirnov tests using Microsoft Excel for Mac Version 16.54. Representative video images are presented in (S1S4 Videos).

Western blot analysis

A previously described method [49] was used with modifications for fractionation of the membrane and cytoplasmic fractions. B. subtilis overnight cultures were washed twice with SMH (0.5 M Sucrose, 20 mM MgCl2, 20 mM HEPES-NaOH pH 7.3) at room temperature. The cells were resuspended in 1/5 the volume of SMH and treated with lysozyme (10 mg/mL). The protoplasts were collected by centrifugation and flash-frozen in liquid nitrogen. Thawed protoplasts were dissolved in 500 μL of Buffer H (20 mM HEPES pH 7.3, 200 mM NaCl, 1 mM DTT, 1 tablet/50 mL protease inhibitor (Complete ULTRA, Roche)). The cell suspension was treated with 2 mM MgCl2, 2 mM CaCl2, DNaseI (0.02 U/μL), and RNaseA (40 μg/mL) at 4°C overnight and used as whole cell fraction. Debris was removed from the whole cell fraction by centrifugation at 6,000 × g for 10 minutes at 4°C [50], and the supernatant was centrifuged at 100,000 × g for 1 hour at 4°C. The pellet was dissolved in 100 μL of Buffer H to make the membrane fraction, and the supernatant was used as the cytosol fraction.

FLAG-tagged MotB was detected according to a previously described method [45]. Sodium dodecyl sulfate (SDS) sample buffer (final 1x) was added to each protein sample and boiled for 5 min. The samples were electrophoresed in a 12.5% SDS-polyacrylamide gel and the proteins were blotted to a 0.45-μm PVDF membrane (Millipore). An anti-DYKDDDDK (anti-FLAG) antibody (Fujifilm, Tokyo, Japan) diluted 1:5,000 in 1x TBST was used as the primary antibody. Horseradish peroxidase RP-conjugated anti-mouse IgG (Promega, Japan) diluted 1:5,000 in 1× TBST was used as the secondary antibody. Signals were detected using an ImageQuant LAS 4000 (Fujifilm, Tokyo, Japan).

Blue native polyacrylamide gel electrophoresis

The membrane fractions of bacterial strains were treated with 0.5% n-dodesyl-β-D-maltoside and electrophoresed in a 4–20% gradient polyacrylamide gel in a EzRun BlueNative buffer (ATTO corp., Tokyo, Japan). The proteins in the gel were transferred to a 0.45-μm PVDF membrane (Millipore) using EzFastBlot HMW buffer (ATTO corp) and subjected to western blot analysis.

Statistics

The statistical analyses were performed using Prism 9 software (GraphPad Software) unless otherwise specified. Relevant information on the statistical tests is provided in the captions of each figure.

Supporting information

S1 Fig. Growth curve of the MotB-overexpressed strain.

50 μL of an OD600-adjusted overnight culture of the vector-transformed strain (WT/EV) and MotB-overexpressed strain (WT/motBOE) were aerobically cultured in 5 mL of LB containing 1 mM IPTG at 37°C. Data shown are the means ± standard errors from four independent experiments.

https://doi.org/10.1371/journal.pone.0300634.s001

(TIF)

S2 Fig. Chemical structural formula of kanamycin and gentamicin.

Chemical structures were constructed by Marvin Sketch of ChemAxon (16.11.21.0).

https://doi.org/10.1371/journal.pone.0300634.s002

(TIF)

S1 Raw images. Original uncropped images for western blots in Fig 4B.

https://doi.org/10.1371/journal.pone.0300634.s003

(TIF)

S2 Raw images. Original uncropped images for SDS polyacrylamide gel electrophoresis and western blots in Fig 5B.

https://doi.org/10.1371/journal.pone.0300634.s004

(TIF)

S3 Raw images. Original uncropped images for western blots in Fig 6D and 6E and a marker in blue native polyacrylamide gel electrophoresis in Fig 6E.

https://doi.org/10.1371/journal.pone.0300634.s005

(TIF)

S1 Video. Video data of swimming and cell tracks of WT/EV.

Swimming of the vector-transformed strain (WT/EV) captured under a bright field microscope (left) and detected cells and trajectories derived from automated tracking using TrackMate (right). Scale bar, 10 μm.

https://doi.org/10.1371/journal.pone.0300634.s006

(MOV)

S2 Video. Video data of swimming and cell tracks of WT/motBOE.

Swimming of MotB-overexpressed strain (WT/motBOE) captured under a bright field microscope (left) and detected cells and trajectories derived from automated tracking using TrackMate (right). Scale bar, 10 μm.

https://doi.org/10.1371/journal.pone.0300634.s007

(MOV)

S3 Video. Video data of swimming and cell tracks of ΔmotB/EV.

Swimming of motB-deletion strain (ΔmotB/EV) captured under a bright field microscope (left) and detected cells and trajectories derived from automated tracking using TrackMate (right). Scale bar, 10 μm.

https://doi.org/10.1371/journal.pone.0300634.s008

(MOV)

S4 Video. Video data of swimming and cell tracks of ΔmotB/motBOE.

Swimming of motB-deletion strain overexpressing MotB (ΔmotB/motBOE) captured under a bright field microscope (left) and detected cells and trajectories derived from automated tracking using TrackMate (right). Scale bar, 10 μm.

https://doi.org/10.1371/journal.pone.0300634.s009

(MOV)

Acknowledgments

We thank the National BioResource Project B. subtilis (National Institute of Genetics, Japan) for providing the BKE library and the Bacillus Genetic Stock Center for providing B. subtilis 168 and plasmids.

References

  1. 1. Davis BD. Mechanism of bactericidal action of aminoglycosides. Microbiol Rev. 1987; 51: 341–350. pmid:3312985
  2. 2. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ. Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death. Cell. 2008; 135: 679–690. pmid:19013277
  3. 3. Bryan LE, Van den Elzen HM. Streptomycin accumulation in susceptible and resistant strains of Escherichia coli and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1976; 9: 928–938. pmid:820248
  4. 4. Damper PD, Epstein W. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob Agents Chemother. 1981; 20: 803–808. pmid:6173015
  5. 5. Taber HW, Mueller JP, Miller PF, Arrow AS. Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987; 51: 439–457. pmid:3325794
  6. 6. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics. Cell. 2007; 130: 797–810. pmid:17803904
  7. 7. Bruni GN, Kralj JM. Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides. Elife. 2020; 9: e58706. pmid:32748785
  8. 8. Bryan LE, Kwan S. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob Agents Chemother. 1983; 23: 835–845. pmid:6351731
  9. 9. Ezraty B, Vergnes A, Banzhaf M, Duverger Y, Huguenot A, Brochado AR, et al. Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway. Science. 2013; 340: 1583–1587. pmid:23812717
  10. 10. Kanner BI, Gutnick DL. Use of neomycin in the isolation of mutants blocked in energy conservation in Escherichia coli. J Bacteriol. 1972; 111: 287–289. pmid:4273171
  11. 11. Vestergaard M, Bald D, Ingmer H. Targeting the ATP synthase in bacterial and fungal pathogens: beyond Mycobacterium tuberculosis. J Glob Antimicrob Resist. 2022; 29: 29–41. pmid:35131507
  12. 12. Berg HC, Anderson RA. Bacteria Swim by Rotating their Flagellar Filaments. Nature. 1973; 245: 380–382. pmid:4593496
  13. 13. Silverman M, Simon M. Flagellar rotation and the mechanism of bacterial motility. Nature. 1974; 249: 73–74. pmid:4598030
  14. 14. Hu H, Santiveri M, Wadhwa N, Berg HC, Erhardt M, Taylor NMI. Structural basis of torque generation in the bi-directional bacterial flagellar motor. Trends Biochem Sci. 2022; 47: 160–172. pmid:34294545
  15. 15. Deme JC, Johnson S, Vickery O, Aron A, Monkhouse H, Griffiths T, et al. Structures of the stator complex that drives rotation of the bacterial flagellum. Nat Microbiol. 2020; 5: 1553–1564. pmid:32929189
  16. 16. Santiveri M, Roa-Eguiara A, Kühne C, Wadhwa N, Hu H, Berg HC, et al. Structure and Function of Stator Units of the Bacterial Flagellar Motor. Cell. 2020; 183: 244–257.e16. pmid:32931735
  17. 17. Manson MD, Tedesco P, Berg HC, Harold FM, Van Der Drift C. A protonmotive force drives bacterial flagella. Proc Natl Acad Sci U S A. 1977; 74: 3060–3064. pmid:19741
  18. 18. Blair DF, Berg HC. The MotA protein of E. coli is a proton-conducting component of the flagellar motor. Cell. 1990; 60: 439–449. pmid:2154333
  19. 19. Imae Y, Atsumi T. Na+-driven bacterial flagellar motors. J Bioenerg Biomembr. 1989; 21: 705–716. pmid:2687262
  20. 20. Asai Y, Kojima S, Kato H, Nishioka N, Kawagishi I, Homma M. Putative channel components for the fast-rotating sodium-driven flagellar motor of a marine bacterium. J Bacteriol 1997; 179: 5104–5110. pmid:9260952
  21. 21. Ito M, Hicks DB, Henkin TM, Guffanti AA, Powers BD, Zvi L, et al. MotPS is the stator-force generator for motility of alkaliphilic Bacillus, and its homologue is a second functional Mot in Bacillus subtilis. Mol Microbiol. 2004; 53: 1035–1049. pmid:15306009
  22. 22. Fukuoka H, Wada T, Kojima S, Ishijima A, Homma M. Sodium-dependent dynamic assembly of membrane complexes in sodium-driven flagellar motors. Mol Microbiol. 2009; 71: 825–835. pmid:19183284
  23. 23. Terahara N, Kodera N, Uchihashi T, Ando T, Namba K, Minamino T. Na+-induced structural transition of MotPS for stator assembly of the Bacillus flagellar motor. Sci Adv. 2017; 3: eaao4119. pmid:29109979
  24. 24. Stolz B, Berg HC. Evidence for interactions between MotA and MotB, torque-generating elements of the flagellar motor of Escherichia coli. J Bacteriol. 1991; 173: 7033–7037. pmid:1938906
  25. 25. Ito M, Terahara N, Fujinami S, Krulwich TA. Properties of motility in Bacillus subtilis powered by the H+-coupled MotAB flagellar stator, Na+-coupled MotPS or hybrid stators MotAS or MotPB. J Mol Biol. 2005; 352: 396–408. pmid:16095621
  26. 26. Zhou J, Sharp LL, Tang HL, Lloyd SA, Billings S, Braun TF, et al. Function of protonatable residues in the flagellar motor of Escherichia coli: a critical role for Asp 32 of MotB. J Bacteriol. 1998; 180: 2729–2735. pmid:9573160
  27. 27. Takahashi Y, Koyama K, Ito M. Suppressor mutants from MotB-D24E and MotS-D30E in the flagellar stator complex of Bacillus subtilis. J Gen Appl Microbiol. 2014; 60: 131–139. pmid:25273986
  28. 28. Santana M, Ionescu MS, Vertes A, Longin R, Kunst F, Danchin A, et al. Bacillus subtilis F0F1 ATPase: DNA sequence of the atp operon and characterization of atp mutants. J Bacteriol. 1994; 176: 6802–11. pmid:7961438
  29. 29. Haldenwang WG, Losick R. A modified RNA polymerase transcribes a cloned gene under sporulation control in Bacillus subtilis. Nature. 1979; 282: 256–60. pmid:116131
  30. 30. Haldenwang WG. The sigma factors of Bacillus subtilis. Microbiol Rev. 1995; 59: 1–30. pmid:7708009
  31. 31. Kojima S, Blair DF. Conformational change in the stator of the bacterial flagellar motor. Biochemistry. 2001; 40: 13041–50. pmid:11669642
  32. 32. Braun TF, Blair DF. Targeted disulfide cross-linking of the MotB protein of Escherichia coli: evidence for two H(+) channels in the stator Complex. Biochemistry. 2001; 40: 13051–9. pmid:11669643
  33. 33. Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl Microbiol Biotechnol. 2006; 70: 140–50. pmid:16391922
  34. 34. Becker B, Cooper MA. Aminoglycoside antibiotics in the 21st century. ACS Chem Biol. 2013; 8: 105–15. pmid:23110460
  35. 35. Feldman MB, Terry DS, Altman RB, Blanchard SC. Aminoglycoside activity observed on single pre-translocation ribosome complexes. Nat Chem Biol. 2010; 6: 244.
  36. 36. Den Blaauwen T, Aarsman ME, Vischer NO, Nanninga N. Penicillin-binding protein PBP2 of Escherichia coli localizes preferentially in the lateral wall and at mid-cell in comparison with the old cell pole. Mol Microbiol. 2003; 47: 539–547. pmid:12519203
  37. 37. Pereira PM, Filipe SR, Tomasz A, Pinho MG. Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2007; 51: 3627–3633. pmid:17646417
  38. 38. Kojima S, Imada K, Sakuma M, Sudo Y, Kojima C, Minamino T, et al. Stator assembly and activation mechanism of the flagellar motor by the periplasmic region of MotB. Mol Microbiol. 2009; 73: 710–718. pmid:19627504
  39. 39. Hosking ER, Vogt C, Bakker EP, Manson MD. The Escherichia coli MotAB proton channel unplugged. J Mol Biol. 2006; 364: 921–937. pmid:17052729
  40. 40. Morimoto YV, Che YS, Minamino T, Namba K. Proton-conductivity assay of plugged and unplugged MotA/B proton channel by cytoplasmic pHluorin expressed in Salmonella. FEBS Lett. 2010; 584: 1268–72. pmid:20178785
  41. 41. Haque MM, Hirata H, Tsuyumu S. SlyA regulates motA and motB, virulence and stress-related genes under conditions induced by the PhoP-PhoQ system in Dickeya dadantii 3937. Res Microbiol. 2015; 166: 467–475. pmid:26027774
  42. 42. Michel E, Mengaud J, Galsworthy S, Cossart P. Characterization of a large motility gene cluster containing the cheR, motAB genes of Listeria monocytogenes and evidence that PrfA downregulates motility genes. FEMS Microbiol Lett. 1998; 169: 341–347. pmid:9868779
  43. 43. Tambalo DD, Del Bel KL, Bustard DE, Greenwood PR, Steedman AE, Hynes MF. Regulation of flagellar, motility and chemotaxis genes in Rhizobium leguminosarum by the VisN/R-Rem cascade. Microbiology. 2010. 156: 1673–1685. pmid:20203055
  44. 44. Koo B-M, Kritikos G, Farelli JD, Todor H, Tong K, Kimsey H, et al. Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis. Cell Syst. 2017; 4: 291–305.e7. pmid:28189581
  45. 45. Ishikawa K, Shirakawa R, Takano D, Kosaki T, Furuta K, Kaito C. Knockout of ykcB, a Putative Glycosyltransferase, Leads to Reduced Susceptibility to Vancomycin in Bacillus subtilis. J Bacteriol. 2022; 204: e0038722. pmid:36409129
  46. 46. Kinosita Y, Ishida T, Yoshida M, Ito R, Morimoto YV, Goto K, et al. Distinct chemotactic behavior in the original Escherichia coli K-12 depending on forward-and-backward swimming, not on run-tumble movements. Sci Rep. 2020; 10: 15887. pmid:32985511
  47. 47. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9: 671–5. pmid:22930834
  48. 48. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9: 676–82. pmid:22743772
  49. 49. Doan T, Morlot C, Meisner J, Serrano M, Henriques AO, Moran CP, et al. Novel Secretion Apparatus Maintains Spore Integrity and Developmental Gene Expression in Bacillus subtilis. PLoS Genetics. 2009; 5: e1000566. pmid:19609349
  50. 50. Eymann C, Dreisbach A, Albrecht D, Bernhardt J, Becher D, Gentner S, et al. A comprehensive proteome map of growing Bacillus subtilis cells. Proteomics. 2004. 4: 2849–2876. pmid:15378759